STOP Persistent AF PAS (NCT05005949)

🧪 Interventions in This Study

• Arctic Front™ Cardiac Cryoablation Catheter System (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (17 Sites)

• Hartford Hospital — Hartford, Connecticut
• Cardiology Associates of Fairfield County — Stamford, Connecticut
• BayCare Medical Group Cardiology — Clearwater, Florida
• Heart Rhythms Solutions — Davie, Florida
• Carle Foundation Hospital — Urbana, Illinois
• Henry Ford Heart & Vascular — Detroit, Michigan
• Spectrum Health Hospitals — Grand Rapids, Michigan
• The Lindner Research Center — Cincinnati, Ohio
• Texas Cardiac Arrhythmia Research Foundation — Austin, Texas
• Texas Health Research & Education Institute — Dallas, Texas
• Kepler Universitätsklinikum Med Campus III. — Linz,
• St. Vinzenz-Hospital Köln — Cologne,
• MVZ CCB Frankfurt und Main Taunus — Frankfurt am Main,
• Städtische Kliniken München GmbH - Klinikum Bogenhausen — München,
• Universitaria Pisana - Stabilimento di Cisanello — Pisa,
• Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodz — Lodz,
• Liverpool Heart and Chest Hospital NHS Foundation Trust — Liverpool,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Persistent Atrial Fibrillation

• Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias — Jonesboro, Arkansas
• Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation — Birmingham, Alabama
• SPHERE Per-AF Post-Approval Study — Birmingham, Alabama
• Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study — Ottawa, Ontario
• REPRESENT-PF Registry — New York, New York

Explore by condition: All Persistent Atrial Fibrillation clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.